Overview
Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2024-02-01
2024-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Assessment of the efficacy of Intratympanic platelet rich plasma injection for treatment of idiopathic suden sensorineural hearing lossPhase:
Phase 2/Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Assiut UniversityTreatments:
Anesthetics
Criteria
Inclusion Criteria:- Patients have sudden idiopathic sensorineural hearing loss
Exclusion Criteria:
1. patients has previous ear surgery.
2. patients has absent cochlea in CT or MRI
3. patients has Cancer,Chronic liver disease, Hemodynamic instability,Hypofibrinogenemia,
Platelet dysfunction syndromes, Systemic disorder, sepsis, Low platelet count.